Herpes zoster opthalmicus in HIV/AIDS

Community Eye Health

Volumn 16, Issue 47, 2003, Pages 35-36

  Wiafe, Boateng ^a  

^a Lusaka Eye Hospital   (Zambia)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMITRIPTYLINE; ANTIBIOTIC AGENT; ANTIVIRUS AGENT; STEROID; TRICYCLIC ANTIDEPRESSANT AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGE; BLEPHARITIS; BLINDNESS; CHORIORETINITIS; CLINICAL FEATURE; CONJUNCTIVITIS; DISEASE COURSE; DRUG INDICATION; EPISCLERITIS; GLAUCOMA; HERPES ZOSTER OPHTHALMICUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENCE; IMPETIGO; INFECTION RISK; KERATITIS; NEURALGIA; OPTIC NERVE DISEASE; PATIENT COMPLIANCE; PTOSIS; RASH; RETINITIS; REVIEW; SCLERITIS; SKIN MANIFESTATION; STEROID THERAPY; SUPERINFECTION; UVEITIS;

EID: 2542485408     PISSN: 09536833     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (4)

1. Pavan-Langston D. Clinical manifestations and therapy of herpes zoster ophthalmicus. Comp Ophthalm Update 2002; 3: 217.
2. Sheikh S, Ta C N. Evaluation and management of herpes zoster ophthalmicus. Am Fam Physician 2002; 66: 1723-1730.
3. Pavan-Langston D. Clinical manifestations and therapy of herpes zoster ophthalmicus. Comp Ophthalm Update 2002; 3: 219.
4. American Academy of Ophthalmology. External Disease and Cornea. Basic Clinical Science Course Manual 1998-1999; 8: 154.